Novo Nordisk A/S Class B's total assets is $590B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Novo Nordisk A/S Class B (NONOF) currently reports a total assets of $590B as of June 2026. That compares with $480B in the prior-year period — up 23.4% year over year. Use the charts on this page to explore Novo Nordisk A/S Class B's total assets history and peer comparisons.
Novo Nordisk A/S Class B's total assets increased from $480B to $590B — a 23.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Novo Nordisk A/S Class B reported $590B in total assets as of June 2026. That compares with $480B in the prior-year period — up 23.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $590B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Novo Nordisk A/S Class B, and consider following NONOF for alerts when major investors trade the stock.
Novo Nordisk A/S Class B is classified in the Healthcare sector. On total assets, it currently shows $590B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NONOF with unrelated industries.